<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Thromboembolic complications after electrical cardioversion (CV) of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) have been attributed to the dislodgment of preexistent left atrial <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> during the resumption of atrial contraction </plain></SENT>
<SENT sid="1" pm="."><plain>Transesophageal echocardiography (TEE) has been used to identify patients without <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e>, who potentially could undergo CV without anticoagulation </plain></SENT>
<SENT sid="2" pm="."><plain>However, embolic events after CV in patients without evidence of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> on TEE have recently been reported </plain></SENT>
<SENT sid="3" pm="."><plain>AIM OF THE STUDY: To evaluate if absence of <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> or prethrombotic conditions such as spontaneous echo contrast or left atrial appendage disfunction can justify electrical CV without <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Seventy-four patients with AF and candidates for CV underwent monoplane TEE </plain></SENT>
<SENT sid="5" pm="."><plain>Patients were cardioverted without anticoagulation in case of: 1) absence of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> and/or spontaneous echocardiographic contrast and 2) good visualization of left atrial appendage, with a well defined peak blood flow velocity greater than 20 cm/sec </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> other cases, patients underwent <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy which started 3 weeks before CV and continued for 4 weeks afterwards </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Forty-six patients, without <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> or "prethrombotic" conditions, did not receive anticoagulation, while 28 followed traditional therapy with <z:chebi fb="8" ids="10033">warfarin</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Four patients with a <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> in the left atrial appendage were identified: 1 died of <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> 3 days after the beginning of anticoagulation, in another one CV was definitely deferred because of the persistence of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> after 1 month of <z:chebi fb="8" ids="10033">warfarin</z:chebi> therapy </plain></SENT>
<SENT sid="9" pm="."><plain>One patient, with left atrial appendage disfunction, died suddenly after 5 days of anticoagulation </plain></SENT>
<SENT sid="10" pm="."><plain>Two patients reverted spontaneously in sinus rhythm </plain></SENT>
<SENT sid="11" pm="."><plain>Two patients refused electrical CV </plain></SENT>
<SENT sid="12" pm="."><plain>The remaining 67 patients underwent electrical CV which was successful in 56 of them </plain></SENT>
<SENT sid="13" pm="."><plain><z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">Cerebral embolism</z:e> occurred 24 hours after CV in one patient who did not receive anticoagulation </plain></SENT>
<SENT sid="14" pm="."><plain>Repeat TEE soon after embolism showed absence of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> or spontaneous echo contrast, but the presence of low flow velocity in the left atrial appendage </plain></SENT>
<SENT sid="15" pm="."><plain>CONCLUSIONS: In patients in AF candidates for CV, exclusion of <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> or prethrombotic conditions by TEE does not exclude the risk of <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> and the need for <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy </plain></SENT>
<SENT sid="16" pm="."><plain>Left atrial appendage function can be stunned or impaired immediately after CV, favouring a thrombogenic milieu and subsequent embolic events </plain></SENT>
<SENT sid="17" pm="."><plain>Therapeutic anticoagulation at the time of as well as after cardioversion is actually recommended </plain></SENT>
</text></document>